Crescent Capital BDC (CCAP) Financials

Crescent Capital BDC (NASDAQ: CCAP) shows a mixed but generally resilient long-term financial profile, with strong operating cash flow in many quarters, but a sharp deterioration in the most recent quarter.

Because CCAP is a business development company, its earnings can be lumpy quarter to quarter, and the balance sheet tends to be heavily influenced by debt financing and dividend payments. Over the last four years, the company has generally maintained a stable asset base and moderate leverage, but recent results point to pressure on profitability and cash generation.

• Operating cash flow was strong in several periods. CCAP produced solid net cash from operating activities in multiple quarters, including Q3 2024 ($46.9 million), Q2 2025 ($36.4 million), and Q1 2026 was still negative but improved less dramatically on a cash basis than the income statement suggests because of non-cash items.
• The balance sheet remained relatively stable over time. Total assets stayed in a fairly narrow range around $1.6 billion to $1.7 billion from early 2023 through Q1 2026, which suggests the company has not experienced major asset erosion.
• Leverage appears manageable for a BDC. Long-term debt hovered roughly in the $840 million to $915 million range across the period, while total equity remained in the mid-$600 million to mid-$700 million range.
• CCAP continued paying dividends. The company consistently returned cash to shareholders, which is important for income-focused investors.
• Share count has been fairly stable. Weighted average basic shares outstanding were generally around 37 million in 2024 and 2025, limiting dilution risk during the period.
• Cash and restricted cash fluctuated, but remained present. Cash and due from banks plus restricted cash ranged meaningfully quarter to quarter, reflecting active balance sheet management rather than a clear structural liquidity problem.
• Net income has been volatile and often driven by nonoperating items. The income statement shows little to no traditional revenue in the provided data, with earnings largely shaped by insurance policy acquisition costs and nonoperating income or expense.
• Some quarters were unusually strong or weak. For example, Q4 2024 showed a large loss, Q1 2025 showed a large loss, and Q4 2025 briefly turned profitable again before Q1 2026 weakened sharply.
• Q1 2026 was a weak quarter. CCAP reported a net loss of $31.0 million, versus a small loss of $0.8 million in Q4 2025 and a profit of $8.5 million in that prior quarter’s cash flow statement, signaling deterioration in recent operating performance.
• Operating cash flow turned sharply negative in Q1 2026. Net cash from operating activities fell to negative $24.0 million, compared with positive $22.6 million in Q4 2025 and positive $36.4 million in Q2 2025.
• Retained earnings have stayed deeply negative. Retained earnings were negative across the entire period and stood at negative $282.0 million in Q1 2026, indicating the company has accumulated significant historical losses.
• Interest-related cash outflows remain sizable. Cash interest paid stayed high across the period, including $17.2 million in Q1 2026, which reinforces the ongoing burden of debt financing.

Bottom line: CCAP has generally managed its balance sheet with stable assets and consistent dividend activity, but recent quarters show clear pressure on earnings and operating cash flow. For retail investors, the key takeaway is that CCAP still looks like a yield-oriented BDC with a functioning balance sheet, but recent results suggest the business has become more fragile and dependent on favorable financing conditions.